Growing Role of Circulatory Death in Organ Donation Revolutionizes Transplantation in the U.S.
In a remarkable shift, the landscape of organ donation in the United States is evolving, with a growing focus on contributions from individuals who die after their heart ceases to beat—known as donation after circulatory death (DCD). A recent comprehensive study conducted by researchers from NYU Langone Health has found that this practice has transitioned from being a rarity to a commonplace procedure in the last quarter century. As the demand for organ transplants surges, this change is pivotal in addressing the critical shortage of available organs.
The study highlights that, as of 2025, nearly half (49%) of all organ donors in the U.S. fall into the DCD category, a significant increase from just 2% in 2000. This increase is commendable as it offers hope to the more than 100,000 Americans currently on the waiting list for life-saving organ transplants, as reported by the United Network for Organ Sharing.
DCD involves the recovery of organs from patients who do not meet brain death criteria and where life support cannot maintain their viability. When families consent to withdraw life support, they are often given the option to do so in an operating room—allowing for the possibility of organ recovery immediately following death. Once life support is discontinued and if the patient dies within a specific timeframe, the organs can be recovered for transplantation. This stands in contrast to traditional organ donations, which primarily stemmed from brain-dead individuals whose organs were supplied with oxygen-rich blood until the point of recovery.
In previous decades, organs harvested from DCD donors were often viewed as less viable due to a period of time during which they could go without oxygen. However, recent advancements in medical technology are changing this narrative. Innovative techniques such as normothermic regional perfusion allow for temporary restoration of blood flow to the organs post-circulatory death. Furthermore, machine perfusion devices, capable of providing oxygen and nutrients to organs after removal, are becoming more prevalent, mitigating the risks associated with DCD. These emerging practices are not only expanding the pool of usable organs but are also allowing the recovery of organs that were previously deemed unsuitable for transplantation.
Interestingly, the characteristics of today's DCD donors are shifting. Research indicates that these donors are often older, possess a higher body mass index, and exhibit more health conditions like diabetes or hypertension compared to their counterparts from earlier years. This change reflects a broader understanding of potential donors, diversifying the range of individuals whose organs may contribute to saving lives.
Despite these advancements, the study’s authors stress the importance of establishing clear standards and guidelines for DCD to ensure patient safety and maintain public trust. SSHospital administrators, healthcare providers, and advocacy groups must prioritize education around this practice as it becomes a more common option in the organ donation process. Open dialogues with patients, families, and medical professionals are vital for building confidence in the DCD process and ensuring its ethical application in organ transplantation.
As the NYU Langone team continues to analyze donor identification practices and recovery efficiency, the focus on improving the long-term outcomes of organs from DCD donors remains a priority. The study illuminates the transformative potential of circulatory death in the organ donation arena, propelling a pivotal change in how organ transplants can be delivered to those in desperate need. Through continued research and advocacy, the potential to save additional lives is more feasible than ever.
The study highlights that, as of 2025, nearly half (49%) of all organ donors in the U.S. fall into the DCD category, a significant increase from just 2% in 2000. This increase is commendable as it offers hope to the more than 100,000 Americans currently on the waiting list for life-saving organ transplants, as reported by the United Network for Organ Sharing.
DCD involves the recovery of organs from patients who do not meet brain death criteria and where life support cannot maintain their viability. When families consent to withdraw life support, they are often given the option to do so in an operating room—allowing for the possibility of organ recovery immediately following death. Once life support is discontinued and if the patient dies within a specific timeframe, the organs can be recovered for transplantation. This stands in contrast to traditional organ donations, which primarily stemmed from brain-dead individuals whose organs were supplied with oxygen-rich blood until the point of recovery.
In previous decades, organs harvested from DCD donors were often viewed as less viable due to a period of time during which they could go without oxygen. However, recent advancements in medical technology are changing this narrative. Innovative techniques such as normothermic regional perfusion allow for temporary restoration of blood flow to the organs post-circulatory death. Furthermore, machine perfusion devices, capable of providing oxygen and nutrients to organs after removal, are becoming more prevalent, mitigating the risks associated with DCD. These emerging practices are not only expanding the pool of usable organs but are also allowing the recovery of organs that were previously deemed unsuitable for transplantation.
Interestingly, the characteristics of today's DCD donors are shifting. Research indicates that these donors are often older, possess a higher body mass index, and exhibit more health conditions like diabetes or hypertension compared to their counterparts from earlier years. This change reflects a broader understanding of potential donors, diversifying the range of individuals whose organs may contribute to saving lives.
Despite these advancements, the study’s authors stress the importance of establishing clear standards and guidelines for DCD to ensure patient safety and maintain public trust. SSHospital administrators, healthcare providers, and advocacy groups must prioritize education around this practice as it becomes a more common option in the organ donation process. Open dialogues with patients, families, and medical professionals are vital for building confidence in the DCD process and ensuring its ethical application in organ transplantation.
As the NYU Langone team continues to analyze donor identification practices and recovery efficiency, the focus on improving the long-term outcomes of organs from DCD donors remains a priority. The study illuminates the transformative potential of circulatory death in the organ donation arena, propelling a pivotal change in how organ transplants can be delivered to those in desperate need. Through continued research and advocacy, the potential to save additional lives is more feasible than ever.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.